Abstract
Aspirin is one of the most commonly prescribed medications for the prevention and treatment of a variety of cardiovascular diseases (CVDs). Routine use of aspirin for the primary prevention of CVD remains controversial and should always be weighed against a patient's risk for bleeding. Aspirin use in primary prevention should be tailored to each individual's risk for adverse cardiac events and prescribed when the risk for CVD significantly outweighs the risk of bleeding. Aspirin continues to be an important medication for reducing adverse CV events in patients with established atherosclerotic disease. However, the evidence for its use in certain cardiac conditions remains limited. Future studies are still warranted to assess the efficacy and safety of aspirin use in the prevention and management of CVD.
Original language | English |
---|---|
Pages (from-to) | 7-21 |
Number of pages | 15 |
Journal | Hot Topics in Cardiology |
Issue number | 32 |
DOIs | |
State | Published - 2013 |